Skip to main content
Toggle navigation
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Red Recording
Sig Meeting
Like
Tweet
Print
Joanna Atkinson, MBChB
Pfizer Ltd, Tadworth, Surrey, UK
Poster(s):
(T 95) A post-hoc assessment of the impact of headache-free interictal period duration and every other day treatment with rimegepant on quality of life scores in a 12-week randomized placebo-controlled trial of migraine prevention
(T 98) Preventive Efficacy of Rimegepant: An Individual Patient Data Meta analysis Across Five Randomized Trials
